#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Red blood cell abnormality Chronic inflammatory demyelinating polyradiculoneuropathy Cardiomyopathy Pustular psoriasis Congenital absence of bile ducts Myxofibrosarcoma Arteriovenous malformation Infertility female Neuroendocrine tumour of the lung Oesophageal squamous cell carcinoma stage II C3 glomerulopathy Hairy cell leukaemia recurrent Idiopathic inflammatory myopathy Synovial sarcoma recurrent Haematological malignancy More trials…

    Learn about Rare Diseases

    Osteosarcoma metastatic – Basic Information MELAS syndrome – Trials in Disease Activated PI3 kinase delta syndrome – Diagnostics Usher’s syndrome – Treatment Marginal zone lymphoma – Diagnostics Pulmonary fibrosis – Basic Information Nephrotic syndrome – Trials in Disease Breast angiosarcoma metastatic – Treatment Familial amyotrophic lateral sclerosis Langerhans’ cell histiocytosis – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Alectinib Ads-010 PROMESTRIENE Aclidinium Bromide Propofol Tiaprofenic Acid USNOFLAST Ampicillin Bms-986449-03 Thiopental Sodium Ucp2 Tertomotide Donepezil Fluasterone Livmoniplimab Abelacimab Bleomycin Sulfate Ph. Eur. Aliskiren Ublituximab VTX2735 SODIUM More therapies…

    Learn about Your Condition

    Dementia with Lewy bodies Ependymoma malignant Myocardial infarction Ventricular tachycardia Malignant lymphoid neoplasm Endocarditis Mitochondrial DNA depletion Breast neoplasm Systemic candida Epilepsy Type IIa hyperlipidaemia Nasopharyngeal cancer Meningococcal infection Ovarian cancer recurrent Myelofibrosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Female Urogenital Diseases and Pregnancy Complications

  • Study on the Effects of Follitropin Beta and Corifollitropin Alfa for Patients with Subfertility Undergoing ICSI Treatment

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Infertility female
    Investigated Drugs:
    • Corifollitropin Alfa
    • Follitropin Beta
    Belgium

  • Study on WT1/IL15/IL15Ra mRNA DC Vaccine for Patients with Advanced or Refractory Solid Tumors of the Pancreas, Esophagus, Liver, or Ovaries

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • Wt1/Il15/Il15Ra Mrna Dc
    Belgium

  • Study on the Effects of Spironolactone, Pioglitazone, and Metformin for Adolescent Girls and Young Women with Polycystic Ovary Syndrome (PCOS)

    Not recruiting

    2 1
    Investigated Drugs:
    • Metformin
    • Pioglitazone
    • Spironolactone
    Austria Denmark Italy Norway Spain

  • Study on the Effect of Triptorelin Before Frozen Embryo Transfer in Patients with Endometriosis or Adenomyosis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Adenomyosis
    • Endometriosis
    Investigated Drugs:
    • Triptorelin
    France

  • Study on Elinzanetant for Treating Hot Flashes in Women with or at High Risk for Hormone-Receptor Positive Breast Cancer

    Not recruiting

    3 1
    Investigated Diseases:
    • Autonomic nervous system imbalance
    • Hot flush
    Investigated Drugs:
    • Elinzanetant
    Austria Belgium Finland France Germany Hungary +6

  • Study of Sacituzumab Govitecan, Zimberelimab, and Domvanalimab for Patients with Muscle Invasive Bladder Cancer Ineligible for Cisplatin Chemotherapy

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Domvanalimab
    • Sacituzumab Govitecan
    • Zimberelimab
    Spain
Previous Page
1 … 24 25 26 27 28 … 32
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!